305 related articles for article (PubMed ID: 6246425)
1. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
[TBL] [Abstract][Full Text] [Related]
5. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
6. Acute renal effects of captopril in patients with congestive heart failure.
Ribstein J; Mimran A
J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
8. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Dzau VJ
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
Ferreira SR; Saragoça MA; Homsi E; Ajzen H; Draibe SA; Ribeiro AB; Ramos OL
J Clin Hypertens; 1987 Dec; 3(4):685-94. PubMed ID: 3330991
[TBL] [Abstract][Full Text] [Related]
10. [Long-term treatment of severe cardiac failure with captopril (author's transl)].
Komajda M; Eugène M; Evans J; Lecossier D; Grosgogeat Y
Nouv Presse Med; 1981 Apr; 10(19):1587-90. PubMed ID: 7025850
[TBL] [Abstract][Full Text] [Related]
11. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
[TBL] [Abstract][Full Text] [Related]
12. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Kawahara Y; Hasegawa K; Sawayama T; Inoue S; Nakamura T; Kakumae S; Tadaoka S; Nakao M; Nezuo S
Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
[TBL] [Abstract][Full Text] [Related]
14. Captopril in heart failure: a double-blind study of the effects on renal function.
Cleland JG; Dargie HJ; Gillen G; Robertson I; East BW; Ball SG; Morton JJ; Robertson JI
J Cardiovasc Pharmacol; 1986; 8(4):700-6. PubMed ID: 2427807
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
16. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
[TBL] [Abstract][Full Text] [Related]
17. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of ularitide in patients with decompensated heart failure.
Lüss H; Mitrovic V; Seferovic PM; Simeunovic D; Ristić AD; Moiseyev VS; Forssmann WG; Hamdy AM; Meyer M
Am Heart J; 2008 Jun; 155(6):1012.e1-8. PubMed ID: 18513512
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Cohn JN; Levine TB
Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
